全文获取类型
收费全文 | 33253篇 |
免费 | 3206篇 |
国内免费 | 4382篇 |
出版年
2024年 | 89篇 |
2023年 | 448篇 |
2022年 | 1087篇 |
2021年 | 1712篇 |
2020年 | 1295篇 |
2019年 | 1711篇 |
2018年 | 1580篇 |
2017年 | 1257篇 |
2016年 | 1524篇 |
2015年 | 2014篇 |
2014年 | 2582篇 |
2013年 | 2665篇 |
2012年 | 3149篇 |
2011年 | 2825篇 |
2010年 | 1817篇 |
2009年 | 1667篇 |
2008年 | 1848篇 |
2007年 | 1584篇 |
2006年 | 1411篇 |
2005年 | 1258篇 |
2004年 | 1202篇 |
2003年 | 1195篇 |
2002年 | 1060篇 |
2001年 | 803篇 |
2000年 | 588篇 |
1999年 | 498篇 |
1998年 | 357篇 |
1997年 | 266篇 |
1996年 | 238篇 |
1995年 | 178篇 |
1994年 | 187篇 |
1993年 | 124篇 |
1992年 | 119篇 |
1991年 | 126篇 |
1990年 | 90篇 |
1989年 | 70篇 |
1988年 | 43篇 |
1987年 | 50篇 |
1986年 | 29篇 |
1985年 | 32篇 |
1984年 | 16篇 |
1983年 | 18篇 |
1982年 | 14篇 |
1981年 | 7篇 |
1980年 | 5篇 |
1979年 | 1篇 |
1950年 | 2篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
921.
Kai Lv Jinwei Wu Jian Wang Mingliang Liu Zengquan Wei Jue Cao Yexin Sun Huiyuan Guo 《Bioorganic & medicinal chemistry letters》2013,23(6):1754-1759
We report herein the synthesis of a series of 7-[3-alkoxyimino-4-(methyl)aminopiperidin-1-yl]quinolone/naphthyridone derivatives. In vitro antibacterial activity of these derivatives was evaluated against representative strains, and compared with ciprofloxacin (CPFX), levofloxacin (LVFX) and gemifloxacin (GMFX). The results reveal that all of the target compounds 19a–c and 20 have considerable Gram-positive activity, although they are generally less active than the reference drugs against the Gram-negative strains with some exceptions. Especially, novel compounds 19a2, 19a4 and 19a5 were found to show strong antibacterial activity (MICs: <0.008–0.5 μg/mL) against all of the tested 15 Gram-positive strains including MRSA, LVFX- and GMFX-resistant MRSE, and CPFX-, LVFX- and GMFX-resistant MSSA. 相似文献
922.
Discovery of a small-molecule inhibitor and cellular probe of Keap1–Nrf2 protein–protein interaction
Longqin Hu Sadagopan Magesh Lin Chen Lili Wang Timothy A. Lewis Yu Chen Carol Khodier Daigo Inoyama Lesa J. Beamer Thomas J. Emge Jian Shen John E. Kerrigan Ah-Ng Tony Kong Sivaraman Dandapani Michelle Palmer Stuart L. Schreiber Benito Munoz 《Bioorganic & medicinal chemistry letters》2013,23(10):3039-3043
A high-throughput screen (HTS) of the MLPCN library using a homogenous fluorescence polarization assay identified a small molecule as a first-in-class direct inhibitor of Keap1–Nrf2 protein–protein interaction. The HTS hit has three chiral centers; a combination of flash and chiral chromatographic separation demonstrated that Keap1-binding activity resides predominantly in one stereoisomer (SRS)-5 designated as ML334 (LH601A), which is at least 100× more potent than the other stereoisomers. The stereochemistry of the four cis isomers was assigned using X-ray crystallography and confirmed using stereospecific synthesis. (SRS)-5 is functionally active in both an ARE gene reporter assay and an Nrf2 nuclear translocation assay. The stereospecific nature of binding between (SRS)-5 and Keap1 as well as the preliminary but tractable structure–activity relationships support its use as a lead for our ongoing optimization 相似文献
923.
Lin Zhou Xuefeng Ge Jihua Liu Jiahong Zhou Shaohua Wei Fuyou Li Jian Shen 《Bioorganic & medicinal chemistry letters》2013,23(19):5317-5324
Hypocrellin A (HA), an a natural perylene quinine photosensitizers (PSs), can chelate with heavy metal ions, including Au(III) and Pt(IV), to form a 1:2 complex, which exhibits enhanced 1O2 generation quantum yield through the increased intersystem crossing efficiency mediated by internal heavy atom effect. Besides, the chelate process greatly improved the water solubility of HA. Comparative studies with HA and complexes have demonstrated that the heavy-atom effect on HA molecules enhances the efficiency of in vitro photodynamic (PDT) efficacy. 相似文献
924.
Guo-Wu Rao Cui Wang Jian Wang Zhen-Guo Zhao Wei-Xiao Hu 《Bioorganic & medicinal chemistry letters》2013,23(23):6474-6480
3,6-Diaryl-dihydro-1,2,4,5-tetrazine derivatives were synthesized and their structures were confirmed by single-crystal X-ray diffraction. Monosubstituted dihydrotetrazines are the 1,4-dihydro structure, but disubstituted dihydrotetrazines are the 1,2-dihydro structure. The results of further research indicated there may be a rearrangement during the synthesis process of disubstituted dihydrotetrazines. Their antitumor activities were evaluated against A-549 and P388 cells in vitro. The results showed several compounds to be endowed with cytotoxicity in the low micromolar range. Two compounds were highly effective against A-549 cell and IC50 values were 0.575 and 2.08 μM, respectively. Three-dimensional quantitative structure–activity relationship (3D-QSAR) studies of comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) were carried out on 37 1,2,4,5-tetrazine derivatives with antitumor activity against A-549 cell. Models with good predictive abilities were generated with the cross validated q2 values for CoMFA and CoMSIA being 0.744 and 0.757, respectively. Conventional r2 values were 0.978 and 0.988, respectively, the predicted R2 values were 0.916 and 0.898, respectively. The results provide the tool for guiding the design and synthesis of novel and more potent tetrazine derivatives. 相似文献
925.
Colin H. MacKinnon Kevin Lau Jason D. Burch Yuan Chen Jonathon Dines Xiao Ding Charles Eigenbrot Alexander Heifetz Allan Jaochico Adam Johnson Joachim Kraemer Susanne Kruger Thomas M. Krülle Marya Liimatta Justin Ly Rosemary Maghames Christian A.G.N. Montalbetti Daniel F. Ortwine Zhonghua Pei 《Bioorganic & medicinal chemistry letters》2013,23(23):6331-6335
Inhibition of the non-receptor tyrosine kinase ITK, a component of the T-cell receptor signalling cascade, may represent a novel treatment for allergic asthma. Here we report the structure-based optimization of a series of benzothiazole amides that demonstrate sub-nanomolar inhibitory potency against ITK with good cellular activity and kinase selectivity. We also elucidate the binding mode of these inhibitors by solving the X-ray crystal structures of several inhibitor-ITK complexes. 相似文献
926.
Zhen-Wei Wu Hai-Wei Xu Gui-Fu Dai Meng-Jiao Liu Li-Ping Zhu Jian Wu Ya-Nan Wang Feng-Juan Wu Dan Zhao Ming-Fu Gao Shan-Shan Nie Wei Han Jing-Hui Song Hong-Min Liu 《Bioorganic & medicinal chemistry letters》2013,23(23):6421-6426
In the present study, andrographolide (Andro, 1) derivatives were screened to identify potent inhibitors against tumor-cell migration and invasion, and associated structure–activity relationships were studied. Compared to 1, compounds 8a–8d exhibited more potent activities against migration in SGC-7901, PC-3, A549, HT-29 and Ec109 cell lines. Improved activities against tumor-cell migration and invasion were proved to be associated with the down-regulation of MMPs. 相似文献
927.
Xiang Li Rostyslav Zvanych Stephanie A. Vanner Wenliang Wang Nathan A. Magarvey 《Bioorganic & medicinal chemistry letters》2013,23(18):5123-5127
Here we report the biosynthetic pathway for the neoantimycin and present three novel neoantimycin analogues, neoantimycin D (1), E (2) and F (3), from this assembly system from Streptoverticillium orinoci. Identification of these novel neoantimycin variants was achieved by selective MS/MS interrogation of natural product extracts using diagnostic fragments of the known neoantimycins. Their structures, including the absolute configurations, were elucidated using a combination of NMR experiments, detailed MS/MS experiments and the advanced Marfey’s method. The biosynthetic pathway of neoantimycin was dissected by genome sequencing data analysis for the first time, which includes a hybrid nonribosomal peptide synthetase (NRPS) and polyketide synthetase (PKS) assembly lines. 相似文献
928.
Yimin Qian David Bolin Karin Conde-Knape Paul Gillespie Stuart Hayden Kuo-Sen Huang Andrée R. Olivier Tsutomu Sato Qing Xiang Weiya Yun Xiaolei Zhang 《Bioorganic & medicinal chemistry letters》2013,23(10):2936-2940
Glycogen synthase (GS) catalyzes the transfer of glucose residues from UDP-glucose to a glycogen polymer chain, a critical step for glucose storage. Patients with type 2 diabetes normally exhibit low glycogen levels and decreased muscle glucose uptake is the major defect in whole body glucose disposal. Therefore, activating GS may provide a potential approach for the treatment of type 2 diabetes. In order to identify non-carboxylic acids GS activators, we designed and synthesized a series of 2-N-alkyl- and 2-N-aryl-indazolone derivatives and studied their activity in activating human GS. 相似文献
929.
Guobin Cai Lisheng Deng Jian Xue Silvia N.J. Moreno Boris Striepen Yongcheng Song 《Bioorganic & medicinal chemistry letters》2013,23(7):2158-2161
The apicomplexan parasite Toxoplasma gondii, the causative agent of toxoplasmosis, is an important human pathogen. 1-Deoxy-d-xylulose-5-phosphate reductoisomerase (DXR) in the non-mevalonate isoprene biosynthesis pathway is essential to the organism and therefore a target for developing anti-toxoplasmosis drugs. In order to find potent inhibitors, we expressed and purified recombinant T. gondii DXR (TgDXR). Biochemical properties of this enzyme were characterized and an enzyme activity/inhibition assay was developed. A collection of 11 compounds with a broad structural diversity were tested against TgDXR and several potent inhibitors were identified with Ki values as low as 48 nM. Analysis of the results as well as those of Escherichia coli and Plasmodium falciparum DXR enzymes revealed a different structure–activity relationship profile for the inhibition of TgDXR. 相似文献
930.
Kevin Anderson Yi Chen Zhi Chen Romyr Dominique Kelli Glenn Yang He Cheryl Janson Kin-Chun Luk Christine Lukacs Ann Polonskaia Qi Qiao Aruna Railkar Pamela Rossman Hongmao Sun Qing Xiang Masha Vilenchik Peter Wovkulich Xiaolei Zhang 《Bioorganic & medicinal chemistry letters》2013,23(24):6610-6615
DYRK1B is a kinase over-expressed in certain cancer cells (including colon, ovarian, pancreatic, etc.). Recent publications have demonstrated inhibition of DYRK1B could be an attractive target for cancer therapy. From a data-mining effort, the team has discovered analogues of pyrido[2,3-d]pyrimidines as potent enantio-selective inhibitors of DYRK1B. Cells treated with a tool compound from this series showed the same cellular effects as down regulation of DYRK1B with siRNA. Such effects are consistent with the proposed mechanism of action. Progress of the SAR study is presented. 相似文献